Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

InspireMD (NSPR) Shares Outstanding (2016 - 2025)

InspireMD filings provide 16 years of Shares Outstanding readings, the most recent being $43.5 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 2533792.96% to $43.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.5 million, a 2533792.96% increase, with the full-year FY2025 number at $43.5 million, up 2533792.96% from a year prior.
  • Shares Outstanding hit $43.5 million in Q4 2025 for InspireMD, up from $41.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $43.5 million in Q4 2025 to a low of $1718.0 in Q2 2021.
  • Median Shares Outstanding over the past 5 years was $7.9 million (2021), compared with a mean of $13.0 million.
  • The widest YoY moves for Shares Outstanding: up 2533792.96% in 2025, down 99.99% in 2025.
  • InspireMD's Shares Outstanding stood at $1718.0 in 2021, then soared by 484819.56% to $8.3 million in 2022, then tumbled by 99.98% to $1718.0 in 2023, then changed by 0.0% to $1718.0 in 2024, then skyrocketed by 2533792.96% to $43.5 million in 2025.
  • The last three reported values for Shares Outstanding were $43.5 million (Q4 2025), $41.9 million (Q3 2025), and $1718.0 (Q2 2025) per Business Quant data.